On November 10, 2021 Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patient’s body, reported that it will take part in two fireside chats, the first at the Stifel Healthcare Conference 2021, November 15-17, and the second at the Jefferies London Healthcare Conference, November 16-19. Both conferences will be held virtually (Press release, Cue Biopharma, NOV 10, 2021, View Source [SID1234608268]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
During the fireside chats, Cue Biopharma will provide an updated corporate overview and recent data highlighting its lead clinical program, CUE-101, representative of the IL-2 based CUE-100 series, as a monotherapy and in combination with KEYRUDA (pembrolizumab) for the treatment of patients with HPV+ recurrent/metastatic head and neck cancer. The discussion will also focus on the Company’s CUE-100 series pipeline progress with drug product candidates CUE-102, targeting Wilms’ Tumor 1 (WT1) and CUE-103, targeting KRAS G12V, as well as its most recent Neo-STAT platform developments.
Presentation Details:
Stifel Healthcare Conference
Date and Time: Monday, November 15, 2:40 p.m. – 3:10 p.m. EST
Webcast link: View Source
A live and archived webcast of the fireside chat will be available on the Events page in the Investor and Media section of the Company’s website at www.cuebiopharma.com. The webcast will be archived for 30 days.
Jefferies Virtual London Healthcare Conference
Date and Time: The pre-recorded fireside chat will be available to conference attendees on-demand between 8:00 a.m. GMT/3:00 a.m. EST on Thursday, November 18 through 5:00 p.m. GMT/12:00 p.m. on Friday, November 19.
A replay of the fireside chat will be hosted on the conference website and available to attendees for 30 days after the event. For more information, email [email protected].
Also, an archived webcast of the fireside chat will be available after the conference on the Events page in the Investor and Media section of the Company’s website at www.cuebiopharma.com. The webcast will be archived for 30 days.